Clinical Trials Logo

Vitrectomy clinical trials

View clinical trials related to Vitrectomy.

Filter by:

NCT ID: NCT00799227 Completed - Clinical trials for Diabetic Macular Edema

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

Start date: January 1, 2009
Phase: Phase 2
Study type: Interventional

The study will evaluate the safety and efficacy of the intravitreal dexamethasone implant in the study eye of vitrectomized subjects with diabetic macular edema. Subjects will be followed for 26 weeks.

NCT ID: NCT00737022 Completed - Clinical trials for Proliferative Diabetic Retinopathy

Macular Appearance After Diabetic Vitrectomy

Start date: May 2005
Phase: N/A
Study type: Observational

Vitrectomy is one of the major treatment methods for complications of diabetic retinopathy. As surgical techniques and instruments improve, high anatomical success may be achieved; however, functional results are less favorable. Despite attached retina, postoperative visual function may be affected by various macular and disc abnormalities. Major changes include optic atrophy, atrophic retina, poor macular perfusion, and structural alternations of the macula. Funduscopy, fluorescein angiography, and, more recently, optical coherence tomography (OCT) can be used to detect and document these alterations. Although fluorescein angiography is valuable in the assessment of various macular lesions as well as retinal vascular abnormalities, its usefulness in evaluating macular changes is limited in eyes that have undergone diabetic vitrectomy. The quality of the images may be compromised by mild diffuse hyperfluorescence in the posterior pole in middle and late phase angiography, which obscures capillary detail and subtle macular changes. Furthermore, quantification of changes may not be possible. Recently, optical coherence tomography has become very useful for the detection of vitreomacular abnormalities. The examination is noninvasive, can qualify the changes and detect subtle abnormalities not evident with other imaging studies. In this study, OCT was applied to investigate how common macular structure abnormalities are present after surgery for complications of diabetic retinopathy, and how they may affect visual prognosis.

NCT ID: NCT00685490 Completed - Vitrectomy Clinical Trials

Vitrectomy for Branch Retinal Vein Occlusion

Start date: July 1995
Phase: N/A
Study type: Observational

To evaluate the long term outcomes of pars plana vitrectomy (PPV), with and without internal limiting membrane (ILM) peeling, in eyes with persistent macular edema secondary to branch retinal vein occlusion (BRVO). Results suggest the following hypothesis: - PPV, with and without ILM peeling, appears to be beneficial in eyes with persistent macular edema due to BRVO - Effectiveness is maintained long term - ILM peeling does not significantly affect postoperative best corrected visual acuity (BCVA)

NCT ID: NCT00532415 Completed - Vitrectomy Clinical Trials

Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy

Start date: September 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of triamcinolone acetonide suspension when used for visualization of structures in the back of the eye during eye surgery.

NCT ID: NCT00412958 Completed - Vitrectomy Clinical Trials

A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

Start date: December 2006
Phase: Phase 2
Study type: Interventional

A multicenter study to compare multiple doses of intravitreal microplasmin in patients undergoing surgical vitrectomy.

NCT ID: NCT00377546 Completed - Vitrectomy Clinical Trials

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Start date: n/a
Phase: Phase 4
Study type: Interventional

To compare the penetration of three different NSAIDs.